systemic lupus erythematosus (sle)
Showing 1 - 25 of 39
Systemic Lupus Erythematosus (SLE) Trial in China (SG301 SC Injection)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- SG301 SC Injection
-
Bengbu, Anhui, China
- +9 more
Nov 17, 2023
Systemic Lupus Erythematosus (Sle) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Nicotinamide Riboside)
Not yet recruiting
- Systemic Lupus Erythematosus (Sle)
- Nicotinamide Riboside
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 15, 2023
Systemic Lupus Erythematosus (SLE) Trial (Descartes-08)
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- (no location specified)
Sep 8, 2023
Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))
Recruiting
- Systemic Lupus Erythematosus (SLE)
- anti-CD19 CAR NK cells (KN5501)
-
Shanghai, ChinaChanghai Hospital
Aug 25, 2023
Systemic Lupus Erythematosus (SLE) Trial (BRL-301)
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- BRL-301
- (no location specified)
Aug 13, 2023
Vasculitis, Systemic Lupus Erythematosus (SLE) Trial in Allschwil (CCX168, Placebo)
Completed
- Vasculitis
- Systemic Lupus Erythematosus (SLE)
- CCX168
- Placebo
-
Allschwil, SwitzerlandCovance Clinical Research Unit (CRU) AG
Aug 2, 2023
Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus Trial in Los Angeles, Atlanta
Recruiting
- Systemic Lupus Erythematosus (SLE)
- +2 more
-
Los Angeles, California
- +1 more
Jul 5, 2023
Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- +5 more
- BRL-301
-
Shanghai, Shanghai, ChinaShanghai ChangZheng hospital
May 7, 2023
3TR Systemic Lupus Erythematosus Study Protocol 2
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- Blood sample
- +4 more
- (no location specified)
Feb 17, 2023
Among Juvenile, Adult, and Late-onset Systemic Lupus
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- clinical and serological differences among juvenile, adult, and late-onset systemic lupus erythematosus in a cohort of SLE patients
- (no location specified)
Feb 10, 2023
Gonadotropin-releasing Hormone Agonist in Ovarian Preservation
Recruiting
- Systemic Lupus Erythematosus (Sle)
- Primary Ovarian Insufficiency (Poi)
-
Bethesda, MarylandNational Institute of Arthritis and Musculoskeletal and Skin Dis
Feb 2, 2023
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Rozibafusp Alfa, Placebo for Rozibafusp Alfa)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- Rozibafusp Alfa
- Placebo for Rozibafusp Alfa
-
Birmingham, Alabama
- +146 more
Feb 1, 2023
Systemic Lupus Erythematosus (SLE) Trial in Zhejiang, Shanghai (Placebo, TJ202 injection)
Terminated
- Systemic Lupus Erythematosus (SLE)
- Placebo
- TJ202 injection
-
Zhejiang, Hangzhou, China
- +1 more
Jan 10, 2023
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Elsubrutinib, Placebo for Elsubrutinib, Upadacitinib)
Completed
- Systemic Lupus Erythematosus (SLE)
- Elsubrutinib
- +3 more
-
Mesa, Arizona
- +159 more
Dec 19, 2022
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)
Active, not recruiting
- Systemic Lupus Erythematosus (SLE)
- VAY736
- +3 more
-
Ciudad Autonoma de Bs As, Buenos Aires, Argentina
- +31 more
Sep 19, 2022
Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,
Recruiting
- Rheumatoid Arthritis
- +8 more
- Moderna mRNA-1273
- +5 more
-
Los Angeles, California
- +24 more
Aug 17, 2022
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (BIIB059, BIIB059-matching )
Recruiting
- Systemic Lupus Erythematosus (SLE)
- BIIB059
- BIIB059-matching placebo
-
Mesa, Arizona
- +280 more
Jul 20, 2022
Systemic Lupus Erythematosus (SLE) Trial (Blood sample, Urine sample, Saliva sample)
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- Blood sample
- +4 more
- (no location specified)
Jul 12, 2022
Healthy Volunteers, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) Trial in Sumida-ku (Placebo, KK4277)
Not yet recruiting
- Healthy Volunteers
- +2 more
- Placebo
- KK4277
-
Sumida-ku, Tokyo, JapanMedical Co. LTA Sumida Hospital
Jun 6, 2022
Systemic Lupus Erythematosus (SLE), Juvenile SLE, Cutaneous Lupus Trial in São Paulo (Thalidomide, Hydroxychloroquine reduced,
Completed
- Systemic Lupus Erythematosus (SLE)
- +2 more
- Thalidomide
- +2 more
-
São Paulo, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021
Lupus Nephritis, Systemic Lupus Erythematosus (SLE) Trial in Paris (Obinutuzumab administration, Administration of
Recruiting
- Lupus Nephritis
- Systemic Lupus Erythematosus (SLE)
- Obinutuzumab administration
- +2 more
-
Paris, FranceInternal medicine, Cochin hospital, APHP
Dec 9, 2021
Systemic Lupus Erythematosus (SLE) Trial in United States (Anifrolumab, Standard of Care)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- Anifrolumab
- Standard of Care
-
New Haven, Connecticut
- +4 more
Nov 18, 2021
Systemic Lupus Erythematosus (SLE) Trial in Canada, United States (AKBM-3031, Placebo)
Completed
- Systemic Lupus Erythematosus (SLE)
- AKBM-3031
- Placebo
-
Birmingham, Alabama
- +18 more
Oct 11, 2021
Systemic Lupus Erythematosus (SLE) Trial in Marseille (polymerase chain reaction (PCR) technique of blood transcriptome
Terminated
- Systemic Lupus Erythematosus (SLE)
- polymerase chain reaction (PCR) technique of blood transcriptome analysis
-
Marseille, FranceHôpital de la conception Assistance Publique Hôpitaux de Marseil
Aug 12, 2021
Systemic Lupus Erythematosus (SLE) Trial in São Paulo (Cyclophosphamide, Methylprednisolone, Prednisone)
Terminated
- Systemic Lupus Erythematosus (SLE)
- Cyclophosphamide
- +3 more
-
São Paulo, Sao Paulo, Brazil
- +1 more
Jul 14, 2021